Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Eisai

www.eisai.com

4-6-10 Koishikawa
Bunkyo-Ku
Tokyo
112-8088
Japan

+81-3-3817-3700

Related Companies

  • Quotient Sciences
  • Lonza
  • Hermes Pharma GmbH
  • Titan Enterprises
  • Actylis – The Partner of Choice
  • Shimadzu UK
  • Copley Scientific
  • ProtaGene
  • Qualicaps
  • Austar
  • Broughton Life Sciences Limited
  • Asynt
  • LB Bohle
  • Vetter Pharma International
  • Starlab
  • Gerresheimer
  • Autoscribe Informatics
  • Romaco Holding GmbH
  • Anton Paar
  • Schott Pharma AG and Co. KGaA

Related Content

FDA grants landmark approval for Alzheimer’s treatment
FDA grants landmark approval for Alzheimer’s treatment
AbbVie and Eisai launch online Humira support tool service
AbbVie and Eisai launch online Humira support tool service
Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy
Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy
Eisai and Biogen announce Phase IV Alzheimer's study design
Eisai and Biogen announce Phase IV Alzheimer's study design
Eisai and Merck combination cancer therapy approved by FDA
Eisai and Merck combination cancer therapy approved by FDA
Eisai makes major investments in drug creation
Eisai makes major investments in drug creation
Therapeutics: lemborexant for sleep disorders
Therapeutics: lemborexant for sleep disorders
Eisai, BMS and H3 Biomedicine announce research collaboration
Eisai, BMS and H3 Biomedicine announce research collaboration
Eisai collaborates in China with CY Biotech
Eisai collaborates in China with CY Biotech
Eisai enters into joint research agreement with the Broad Institute, Colorado State University and University of Chicago
Eisai enters into joint research agreement with the Broad Institute, Colorado State University and University of Chicago
AbbVie and Eisai obtain additional approval for Humira
AbbVie and Eisai obtain additional approval for Humira
Eisai enters into agreement with Adlai Nortye for potential anticancer agent
Eisai enters into agreement with Adlai Nortye for potential anticancer agent
Patent battle for Aloxi in the US
Patent battle for Aloxi in the US
Safinamide to be made available in Asia for Parkinson's
Safinamide to be made available in Asia for Parkinson's
Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc
Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company